RCM
VHAQ.RT

Radcliffe Capital Management’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Radcliffe Capital Management’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61,156
Closed -$3.21K – 185
2023
Q4 		$3.21K Sell
61,156
-263,844
-81% -$14.9K ﹤0.01% 157
2023
Q3 		$18.9K Hold
325,000
– – ﹤0.01% 277
2023
Q2 		$18.6K Hold
325,000
– – ﹤0.01% 343
2023
Q1 		$18K Buy
325,000
+308,750
+1,900% +$27.8K ﹤0.01% 441
2022
Q4 		$173K Hold
16,250
– – 0.01% 837
2022
Q3 		$168K Hold
16,250
– – ﹤0.01% 1146
2022
Q2 		$167K Hold
16,250
– – ﹤0.01% 1199
2022
Q1 		$164K Hold
16,250
– – ﹤0.01% 1189
2021
Q4 		$163K Hold
16,250
– – ﹤0.01% 1033
2021
Q3 		$162K Hold
16,250
– – ﹤0.01% 881
2021
Q2 		$161K Sell
16,250
-16,250
-50% -$3.35K 0.01% 901
2021
Q1 		$319K Buy
+32,500
New +$7.59K 0.01% 666

Other funds holding VHAQ.RT

SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Radcliffe Capital Management's VHAQ.RT Position: Q1 2024 in Review

Radcliffe Capital Management sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 61,156 shares — an estimated $3.21K sold.

Radcliffe Capital Management first reported a position in VHAQ.RT in Q1 2021 and held it in 12 quarters. The position peaked at $319K in Q1 2021. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Radcliffe Capital Management reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 61,156 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $3.21K.
  • Radcliffe Capital Management first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2021 and held it in 12 quarters.
  • Radcliffe Capital Management's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $319K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Radcliffe Capital Management's 13F filing for Q1 2024, filed 15 May 2024.